Alpha 2.0
Login Register
» Authors » Andrew Bubak

Andrew Bubak

Explore the profile of Andrew Bubak including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 40
Followers 0
Related Specialties
Oncology
Cell Biology
General Medicine
Top 10 Co-Authors
Kimberly Jordan
Shilpa Bhatia
Kimberly Atiyeh
Von Samedi
Ashesh Thaker
Miles Piper
Jessica D McDermott
Julie Goddard
Jennifer Backus
Robert Hoyer
Published In
Nat Cancer
Stem Cell Reports
Cell Death Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
Darragh L, Knitz M, Hu J, Clambey E, Backus J, Dumit A, et al.
Nat Cancer . 2024 Jan; 5(1):210. PMID: 38200246
No abstract available.
2.
Multiple sclerosis plasma IgG aggregates induce complement-dependent neuronal apoptosis
Zhou W, Graner M, Paucek P, Beseler C, Boisen M, Bubak A, et al.
Cell Death Dis . 2023 Apr; 14(4):254. PMID: 37031195
Grey matter pathology is central to the progression of multiple sclerosis (MS). We discovered that MS plasma immunoglobulin G (IgG) antibodies, mainly IgG1, form large aggregates (>100 nm) which are...
3.
Author Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
Darragh L, Knitz M, Hu J, Clambey E, Backus J, Dumit A, et al.
Nat Cancer . 2022 Dec; 4(1):148. PMID: 36577897
No abstract available.
4.
A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
Darragh L, Knitz M, Hu J, Clambey E, Backus J, Dumit A, et al.
Nat Cancer . 2022 Nov; 3(11):1300-1317. PMID: 36434392
Five-year survival for human papilloma virus-unrelated head and neck squamous cell carcinomas remain below 50%. We assessed the safety of administering combination hypofractionated stereotactic body radiation therapy with single-dose durvalumab...
5.
Modeling Hypoxia-Induced Neuropathies Using a Fast and Scalable Human Motor Neuron Differentiation System
Hudish L, Bubak A, Triolo T, Niemeyer C, Lorberbaum D, Sussel L, et al.
Stem Cell Reports . 2021 Apr; 16(4):1009. PMID: 33852882
No abstract available.
6.
Modeling Hypoxia-Induced Neuropathies Using a Fast and Scalable Human Motor Neuron Differentiation System
Hudish L, Bubak A, Triolo T, Niemeyer C, Lorberbaum D, Sussel L, et al.
Stem Cell Reports . 2020 May; 14(6):1033-1043. PMID: 32386561
Human motor neuron (MN) diseases encompass a spectrum of disorders. A critical barrier to dissecting disease mechanisms is the lack of appropriate human MN models. Here, we describe a scalable,...